Imaging the solitary pulmonary nodule

Area of Science:

• Radiology and Oncology
• Medical Imaging Technology

Background:

• Widespread lung cancer screening programs are increasing thoracic computed tomography (CT) examinations.
• This leads to a rise in the detection of indeterminate solitary pulmonary nodules (SPNs).
• Accurate assessment of SPNs is crucial for timely lung cancer diagnosis and treatment.

Purpose of the Study:

• To review the role of advanced imaging techniques in evaluating indeterminate solitary pulmonary nodules.
• To discuss the potential of newer technologies in improving the diagnostic accuracy for potentially malignant SPNs.

Main Methods:

• Review of current literature on imaging modalities for SPN assessment.
• Discussion of fluorodeoxyglucose F 18 (FDG)-positron emission tomography (PET) utility.
• Exploration of emerging technologies like contrast-enhanced dual-energy chest CT and FDG-PET/CT.

Main Results:

• FDG-PET provides valuable information for assessing indeterminate SPNs.
• Contrast-enhanced dual-energy chest CT shows promise in nodule characterization.
• FDG-PET/CT integrates metabolic and anatomical information for enhanced diagnostic capability.

Conclusions:

• Advanced imaging, including FDG-PET/CT, is essential for managing the increasing number of indeterminate SPNs detected through lung cancer screening.
• These technologies can improve the differentiation between benign and malignant nodules, guiding patient management.
• Further research and clinical integration of these advanced techniques are warranted.